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The clinical interest in the therapeutic use of mesenchymal
stromal/stem cells (MSC) is further increasing as their versa-
tility in animal trial settings becomes more and more obvi-
ous. Indeed, screening the oﬃcial review site for clinical
trials (http://www.clinicaltrials.gov) using the search term
“Mesenchymal Stem Cells” reveals 611 records (September,
2017). The large diversity of medical indications for treat-
ment with MSC comprises hematological malignancies, dia-
betes type 1, neurologic diseases, joint and bone diseases,
organ transplantation, or liver diseases, just to mention a
small selection. This indicates the big potential of MSC to
act beneﬁcially both on chronic and acute diseases of either
local or systemic origin. However, albeit we are only starting
to understand the mode of action of MSC in certain disease
conditions, there is still hesitation on the safety, upscale
feasibility and, eﬀectiveness of clinical MSC application.
MSC from diﬀerent tissues and organs feature rather
similar phenotypic characteristics when put in culture. These
include the capacity of plastic adherence, multiple diﬀerenti-
ation potential, and surface marker proﬁles, which comprise
the minimal deﬁnition criteria for MSC [1]. But gaining
knowledge of molecular signatures by global gene expression
analyses currently reveals that heterogeneity exists between
diﬀerent MSC populations depending on their origin, isola-
tion and propagation procedures, and on their status of
diﬀerentiation [2–5]. The actions mediated by MSC may
comprise two principally diﬀerent mechanisms. The one is
based on the functional integration of diﬀerentiated MSC
into diseased host tissue after transplantation as has been
shown for liver regeneration after partial hepatectomy or
toxic injury [6, 7]. The second mechanism comprises para-
crine or cellular support of self-restoration of the diseased
tissue or organ [8, 9]. The impact of MSC on the regulation
of both the innate and the acquired immune system was
intensively investigated and sparked the application in the
setting of organ transplantation, where immunosuppression
of alloreactivity is essential to prevent rejection [10, 11]. It
is mainly the involvement of key molecules like prostaglan-
din E2 (PGE2), indoleamine 2,3-dioxygenase, cytokines,
and other growth factors, which act on cells of the immune
system to activate or modulate their activity state and thus
to impact on the immune status of the organ or organism
as a whole.
Knowledge on the cellular targets of MSC actions is
emerging. Yet, gain of knowledge still remains limited.
Especially, eﬀects on cell cycle and metabolism remain elu-
sive which however are essential to predict potential
adverse eﬀects in the treatment of tumorigenic diseases
like hepatitis [12] or diseases associated with the metabolic
syndrome like diabetes type 2. Facing the pleiotropic prop-
erties of MSC like modulation of immune responses and
alleviation of inﬂammation and tissue damage, as well as
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stimulation of tissue regeneration, it will be the goal of
future eﬀorts using relevant cell or animal model systems
to unequivocally elucidate the molecular and cellular
impact of a deﬁned MSC population on a speciﬁed disease
environment before their clinical application. In this spe-
cial issue of Stem Cells International on the cellular and
molecular mechanisms of MSC actions (CMMM), we pro-
vide a collection of work stepping towards this goal in
order to complement gaps of knowledge before unequivo-
cal use of MSC in clinical settings
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